Gossamer Bio Inc

Gossamer Bio Inc (GOSS) SEC filings

Gossamer Bio Inc (GOSS) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.

Those exhibit numbers sit next to the income-statement cache: Latest reported GOSS revenue for 2025-09-30 was $13.3M. Net income was -$123.1M. Revenue was up 15.7% from 2025-06-30 to 2025-09-30. GOSS currently screens at market cap $47.0M. The GOSS filings page is the source view; the stock page is the research view.

EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Gossamer Bio Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.

0

10-K

0

10-Q

6

8-K

0

Form 4

Recent filings

8-K5.039.01

8-K exhibit

EDGAR
8-K1.013.025.03

8-K exhibit

EDGAR
8-K5.025.035.07

8-K exhibit

EDGAR
8-K7.019.01

8-K exhibit

EDGAR
8-K1.011.022.03

8-K exhibit

EDGAR
8-K5.07

8-K exhibit

EDGAR

EDGAR is the official archive. Browse all GOSS filings.

Frequently asked questions

What did GOSS just say?

GOSS cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.

Where are GOSS SEC filings?

6 cached filings are on this page. EDGAR remains the official archive (CIK 0001728117).

What is an 8-K Item 2.02?

Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.